Assessment of tissue elasticity and lipid content by using ultrasound and its clinical implication

Assessment of tissue elasticity and lipid content by using ultrasound and its clinical implication - Assessment of tissue elasticity and its clinical implication

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047747

Enrollment

150

Registered

2022-05-15

Start date

2022-05-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity, diabetes, insulin resistance, glucose intolerance, chronic kidney disease, hypertension, dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The outpatients (who are older than or equal to 20 years old) in the Division of Endocrinology Metabolism and Nephrology, Keio University Hospital who have given written informed consent to this study.

Exclusion criteria

Exclusion criteria: The outpatients who do not give written informed consent to this study.

Design outcomes

Primary

Measure	Time frame
The relationship between tissue (subcutaneous adipose tissue, liver, kidney) elasticity and hepatic lipid content and clinical data including; 1)Medical record (e.g. height, weight, blood pressure, age, sex) 2)Medical prognosis 3)Blood and urine tests (e.g. glucose, HbA1c, TC, LDL-C, HDL-C, TG, Cre, BUN, Alb, AST, ALT, gGTP, ALP, U-TP/Cre) 4)Physiological function test (e.g. electrocardiogram, echocardiography) 5)Imaging data (e.g. computed tomography (CT))	—

Measure

Time frame

The relationship between tissue (subcutaneous adipose tissue, liver, kidney) elasticity and hepatic lipid content and clinical data including; 1)Medical record (e.g. height, weight, blood pressure, age, sex) 2)Medical prognosis 3)Blood and urine tests (e.g. glucose, HbA1c, TC, LDL-C, HDL-C, TG, Cre, BUN, Alb, AST, ALT, gGTP, ALP, U-TP/Cre) 4)Physiological function test (e.g. electrocardiogram, echocardiography) 5)Imaging data (e.g. computed tomography (CT))

—

Countries

Japan

Contacts

Public ContactJun Yoshino

Keio University School of Medicine Division of Endocrinology, Metabolism, and Nephrology

jyoshino@keio.jp03-3353-1211

Outcome results